Choose an ELN that holds up under audit
ELNs for regulated environments: Part 11, Annex 11, GxP, ALCOA+, and the questions to ask every vendor.
For labs in pharma, biotech, and medical devices, choosing an electronic lab notebook is a compliance decision, and that changes what good looks like. Many labs select an ELN on ease of use, price, or brand familiarity, then discover during an FDA inspection, a GMP audit, or a data integrity review that the system does not meet the requirements their industry demands. Choose an ELN that holds up under audit covers what compliance requires, what auditors check, and the questions to ask vendors before you sign anything.
What makes an ELN compliant for regulated labs?
A compliant ELN behaves correctly under scrutiny. Under 21 CFR Part 11, that means a complete, time-stamped audit trail that keeps the original value before any change, electronic signatures uniquely linked to the signer with the date, time, and meaning of the signature, access controls that prevent unauthorized changes, a validated system, and records that stay retained, retrievable, and readable for the required period. A vendor claim that a system is “Part 11 ready” does not prove that your implementation is validated, and the data the ELN produces must also meet ALCOA+ by design.
Who this guide is for
R&D, quality, and lab operations teams in pharma, biotech, and medical devices who are evaluating an ELN for the first time, replacing a legacy system, or checking whether a current ELN holds up under regulatory scrutiny.
For a one-page overview of how Uncountable approaches this, read the solution brief A fully searchable ELN.
What's inside
Inside this guide:
- What “regulated” means: 21 CFR Part 11, EU Annex 11, GxP, and ALCOA+
- The six requirements a Part 11 ELN must meet, and what to see in a live system
- Computer system validation, from user requirements to IQ, OQ, PQ, and change control
- What each ALCOA+ principle means in practice
- How GLP, GMP, and GCP ask different things of an ELN
- 19 questions to ask every ELN vendor, from audit trails to data portability and security
- Why a compliance-only ELN can become a data silo
- What auditors check during an inspection, plus key takeaways
Your next audit starts with the records your ELN creates today. Download the guide.
FAQs
For an ELN, the key 21 CFR Part 11 requirements are audit trails that record who created, modified, or deleted a record and the original value; electronic signatures uniquely linked to the signer with the date, time, and meaning of the signature; access controls; system validation; and record retention and retrievability for the required period. A password-only login is not a compliant electronic signature.
ALCOA+ is the data integrity framework requiring records to be Attributable, Legible, Contemporaneous, Original, Accurate, Complete, Consistent, Enduring, and Available. Regulators evaluate whether the data an ELN produces meets these principles, so the system should support them by design rather than through workarounds.
Computer System Validation is the buyer's responsibility, but the vendor's approach matters. A vendor who provides detailed validation documentation and supports your IQ/OQ/PQ process can significantly reduce the burden on your team, while a vendor who only provides templates leaves you with most of the work.
Auditors typically look for complete audit trails for modified records, evidence that electronic signatures are uniquely linked to individuals, proof of system validation including IQ/OQ/PQ and change control records, the ability to retrieve specific records quickly and completely, and consistency between what the system is validated to do and how it is actually used.
R&D, quality, and lab operations teams in pharma, biotech, and medical devices who are evaluating ELNs for the first time, replacing a legacy system, or checking whether a current ELN holds up under regulatory scrutiny.
See the Platform Behind the Guide
